Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
BOSTON, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology...
AILERON THERAPEUTICS INC NASDAQ false 0001420565 --12-31 0001420565 2022-11-10 2022-11-10 UNITED STATES SECURITIES AND EXCHANGE...
BOSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology...
--12-310001420565falseQ3P56D0001420565alrn:UmicoreAgreementMember2006-12-3100014205652022-07-012022-09-300001420565alrn:CommonWarrantsMember2019...
Activated multiple existing and new sites under amended Phase 1b breast cancer clinical trial protocol;...
p53-mediated cell cycle arrest results demonstrate potential of ALRN-6924 to prevent chemotherapy-induced...
New ex vivo data demonstrates protection against cyclophosphamide-induced damage to hair follicles and their...
BOSTON, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology...
BOSTON, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology...
Company continues to advance ALRN-6924 as a selective chemoprotective agent for all patients with p53-mutated...
Enhancements to protocol, informed by recent ALRN-6924 data, are designed to improve the opportunity to...
BOSTON, July 08, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology...
Patients on ALRN-6924 were able to stay on treatment longer, completing more of the first 4 cycles of...
Table of Contents Filed Pursuant to Rule 424(b)(5)Registration No. 333-265470 ...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지